Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bristol-Myers Squibb has chosen Icon as a preferred provider for full-service clinical pharmacology and exploratory clinical studies.
Subscribe to our email newsletter
Under the agreement, Icon will provide clinical pharmacology and exploratory clinical trial services including study conduct in Icon’s clinical pharmacology units, located in San Antonio, Texas; Omaha, Nebraska; and Manchester, UK.
Icon will also provide all supporting scientific services such as protocol design and development, project management, clinical monitoring, medical monitoring / pharmacovigilence, data management, biostatistics, pharmacokinetics and medical writing.
Icon Development Solutions president Mario Rocci said both companies already have a successful partnership for phase II-IV clinical development and central laboratory services and they look forward to demonstrate the same value and efficiencies to Bristol-Myers-Squibb‘s early phase clinical programs.